A baker's-dozen of venture updates, including ClearTrack, TraceFemcare, Writerly, Invergarry, Swingzen and more.
[Updated] Jumpstart Capital, Jumpstart Health Investors, Jumpstart Nova, Jumpstart Foundry play complementary roles.
PE-backed CEO's vision for Endeavor warrants keeping IPO among longer-term growth options.
[updated] NCN is most concerned about the Series A hurdle for startups in the Nashville area.
Vic Gatto and Marcus Whitney are creating an important fund, and exit accelerator universe.
[Updated] nPhase CEO identified. Software with global users and a serious track record is a friendly target.
CEO Chris Ferrell says plans not firm yet for SA.
Serial entrepreneur says he's preparing to 'chase his passion' for venture.
[Updated] Investors bide their time, to catch the wave they see building.
[updated] Chris Ferrell will focus on operations, while Cygnus exec takes the company's helm
Council doubles-down on mail-order institutional pharmacy startup
[UPDATED] A newly created healthcare fund gives the nod to a Nashville startup, plus updates from XMi, Shareable Ink and more
Airing of issues simmering beneath TNInvestco's surface has prompted a reprise of comments pro and con the program
Four business leaders formed the core of group that picked the NEC's inaugural board
Updates on 20-firm TNInvestco roster, TBA board members, Healthways' strategic hire, Bill Frist, Entrepreneurs deadline, StartupWeekend, Universal Robotics, Barcamp
[Updated] With the VC filing deadline just 13 days away, one administrator of the state's new capital-formation program is impressed with the calibre of prospective fund managers
Jacobson's new digs, Universal Robotics' placement, WSJ taps local analysts, Solidus' stake, antitrust cautions and more...
Tennessee executives see both problems and opportunities in proposal for stimulation of early-stage investment
The state's new private-equity director debuts and a VC panel gets the lowdown on controversial venture-funding proposal
Townes Duncan and Vic Gatto now say grace over quite a clutch of portfolio companies
A supposed transformation of education, plus sustained support from key moneymen seem to have given ALS staying-power
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: